Literature DB >> 21399668

Prognostic impact of iron parameters in patients undergoing allo-SCT.

G N Bazuaye1, G N Bazuave, A Buser, S Gerull, A Tichelli, M Stern.   

Abstract

Iron overload contributes to increased transplant-related mortality, and serum ferritin is typically used to detect iron overload. Other iron parameters have received limited attention. We studied serum ferritin, transferrin, transferrin saturation, iron, soluble transferrin receptor (sTfR) and C-reactive protein (CRP) levels in 230 consecutive patients undergoing myeloablative allo-SCT. All iron parameters were significantly associated with survival. When analyzed individually, both sTfR and transferrin saturation were superior in prognostic power to ferritin (areas under the curve in receiver operating characteristic analysis: 0.670, 0.715, and 0.657, respectively). A combination of ferritin and transferrin saturation had the highest prognostic power: Patients with ferritin below the 30th percentile (<802 ng/mL) showed excellent survival (70±6% at 5 years), while transferrin saturation above the 80th percentile (≥69%) pointed to a high risk of transplant failure (5-year survival 5±5%). The remaining patients showed an intermediate outcome (5-year survival 52±5%). The prognostic impact of iron parameters was independent of other factors such as stage, conditioning regimen and CRP level, and operated similarly across diseases. Iron overload strongly influenced the outcome of allo-SCT. Low pre-transplant ferritin levels indicate a population at low risk, high transferrin saturations and a subgroup of patients with very poor outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21399668     DOI: 10.1038/bmt.2011.13

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  13 in total

1.  Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis.

Authors:  Philippe Armand; Haesook T Kim; Johanna M Virtanen; Riitta K Parkkola; Maija A Itälä-Remes; Navneet S Majhail; Linda J Burns; Todd DeFor; Bryan Trottier; Uwe Platzbecker; Joseph H Antin; Martin Wermke
Journal:  Biol Blood Marrow Transplant       Date:  2014-04-24       Impact factor: 5.742

2.  Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation.

Authors:  L Chee; M Tacey; B Lim; A Lim; J Szer; D Ritchie
Journal:  Bone Marrow Transplant       Date:  2017-05-15       Impact factor: 5.483

3.  Does iron overload really matter in stem cell transplantation?

Authors:  Philippe Armand; Marie-Michele Sainvil; Haesook T Kim; Joanna Rhodes; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Ellis J Neufeld; Raymond Y Kwong; Robert J Soiffer; Joseph H Antin
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

Review 4.  Iron overload in myelodysplastic syndromes (MDS).

Authors:  Norbert Gattermann
Journal:  Int J Hematol       Date:  2017-11-25       Impact factor: 2.490

5.  Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.

Authors:  Warren Fingrut; Arjun Law; Wilson Lam; Fotios V Michelis; Auro Viswabandya; Jeffrey H Lipton; Rajat Kumar; Jonas Mattsson; Dennis Dong Hwan Kim
Journal:  Ann Hematol       Date:  2021-01-07       Impact factor: 3.673

6.  Iron overload during follow-up after tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma.

Authors:  Soo Jin Bae; Christine Kang; Ki Woong Sung; Hee Won Chueh; Meong Hi Son; Soo Hyun Lee; Keon Hee Yoo; Hong Hoe Koo
Journal:  J Korean Med Sci       Date:  2012-03-21       Impact factor: 2.153

7.  Long-term eltrombopag for bone marrow failure depletes iron.

Authors:  David J Young; Xing Fan; Emma M Groarke; Bhavisha Patel; Ronan Desmond; Thomas Winkler; Andre Larochelle; Katherine R Calvo; Neal S Young; Cynthia E Dunbar
Journal:  Am J Hematol       Date:  2022-03-26       Impact factor: 13.265

8.  Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content.

Authors:  Bryan J Trottier; Linda J Burns; Todd E DeFor; Sarah Cooley; Navneet S Majhail
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

9.  Long-term follow-up after allogeneic stem cell transplantation in patients with myelodysplastic syndromes or secondary acute myeloid leukemia: a single center experience.

Authors:  Alexandra Boehm; Wolfgang R Sperr; Peter Kalhs; Hildegard Greinix; Peter Valent; Nina Worel; Alexander Kainz; Margit Mitterbauer; Marija Bojic; Werner Rabitsch
Journal:  Wien Klin Wochenschr       Date:  2013-11-19       Impact factor: 1.704

10.  Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.

Authors:  E M P Cremers; A van Biezen; L C de Wreede; M Scholten; A Vitek; J Finke; U Platzbecker; D Beelen; R Schwerdtfeger; L Volin; N Harhalakis; N Blijlevens; A Nagler; N Kröger; T de Witte
Journal:  Ann Hematol       Date:  2016-09-20       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.